152
Views
0
CrossRef citations to date
0
Altmetric
Review

Effective early diagnosis for NSCLC: an algorithm

ORCID Icon, , , ORCID Icon, , , , , , , , , & show all
Pages 1437-1445 | Received 07 May 2021, Accepted 05 Aug 2021, Published online: 23 Aug 2021

References

  • Zarogoulidis P, Petridis D, Sapalidis K, et al. Lung cancer biopsies: comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA. J Cancer. 2020;11(21):6454–6459.
  • Zaric B, Stojsic V, Carapic V, et al. Radial Endobronchial Ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions. J Cancer. 2016;7(1):7–13.
  • Oezkan F, Khan A, Zarogoulidis P, et al. Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses. Onco Targets Ther. 2014;7:2061–2065.
  • Sapalidis K, Zarogoulidis P, Petridis D, et al., EBUS-TNBA 22G samples: comparison of PD-L1 expression between DAKO and BIOCARE((R)). J Cancer. 10(20): 4739–4746. 2019.
  • Zaric B, Stojsic V, Sarcev T, et al. Advanced bronchoscopic techniques in diagnosis and staging of lung cancer. J Thorac Dis. 2013;5(Suppl 4):S359–370.
  • Hohenforst-Schmidt W, Banckwitz R, Zarogoulidis P, et al., Radiation exposure of patients by cone beam CT during endobronchial navigation - a phantom study. J Cancer. 5(3): 192–202. 2014.
  • Hohenforst-Schmidt W, Zarogoulidis P, Vogl T, et al. Cone Beam Computed tomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime Navigation. J Cancer. 2014;5(3):231–241.
  • Sepehri S, Tankyevych O, Upadhaya T, et al. Cheze Le Rest C. Comparison and fusion of machine learning algorithms for prospective validation of PET/CT radiomic features prognostic value in stage II-III non-small cell lung cancer. Diagnostics. 2021;11(4):675.
  • Al-Ibraheem A, Hirmas N, Fanti S, et al., Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC. BMC Med Imaging. 21(1): 49. 2021.
  • Lin J, Ost DE. Robotic bronchoscopy for peripheral pulmonary lesions: a convergence of technologies. Curr Opin Pulm Med. 2021;27(4):229–239.
  • Sumi T, Shijubou N, Sawai T, et al. Transbronchial needle aspiration with endobronchial ultrasonography and ultrathin bronchoscopy for peripheral pulmonary lesions. Respir Investig. 2021. https://doi.org/10.1016/j.resinv.2021.04.004
  • Tsoulos N, Papadopoulou E, Metaxa-Mariatou V, et al. Tumor molecular profiling of NSCLC patients using next generation sequencing. Oncol Rep. 2017;38(6):3419–3429.
  • Zarogoulidis K, Zarogoulidis P, Darwiche K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5(Suppl 4):S389–396.
  • Domvri K, Darwiche K, Zarogoulidis P, et al. Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy. Transl Lung Cancer Res. 2013;2(4):256–258.
  • Domvri K, Zarogoulidis P, Darwiche K, et al., Molecular targeted drugs and biomarkers in NSCLC, the evolving role of individualized therapy. J Cancer. 4(9): 736–754. 2013.
  • Sakoda LC, Rivera MP, Zhang J, et al. Patterns and factors associated with adherence to lung cancer screening in diverse practice settings. JAMA Network Open. 2021;4(4):e218559.
  • Desai A, Prasad V. Low-dose computed tomographic screening for lung cancer: time to implement or unresolved questions? J Gen Intern Med. 2021. https://doi.org/10.1007/s11606-021-06806-5
  • Shiroshita A, Kurosaki M, Takeshita M, et al. Medical thoracoscopy, computed tomography-guided biopsy, and ultrasound-guided biopsy for malignant pleural mesothelioma: a systematic review. Anticancer Res. 2021;41(5):2217–2225.
  • Zhang HM, Huo XB, Wang HL, et al. Computed tomography-guided cutting needle biopsy for lung nodules: a comparative study between low-dose and standard dose protocols. Medicine (Baltimore). 2021;100(3):e24001.
  • Huang Z, Huang H, Ning Y, et al. Radial probe endobronchial ultrasound assisted conventional transbronchial needle aspiration in the diagnosis of solitary peribronchial pulmonary lesion located in the segmental bronchi. J Cancer. 2019;10(3):634–642.
  • Kalanjeri S, Abbasi A, Luthra M, et al. Invasive modalities for the diagnosis of peripheral lung nodules. Expert Rev Respir Med. 2021:781–790.
  • Oh JH, Choi CM, Kim S, et al. Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodules. Thorac Cancer. 2021;12(10):1503–1510.
  • Zheng X, Wang L, Chen J, et al. Diagnostic value of radial endobronchial ultrasonographic features in predominant solid peripheral pulmonary lesions. J Thorac Dis. 2020;12(12):7656–7665.
  • Hohenforst-Schmidt W, Zarogoulidis P, Huang H, et al. A new and safe mode of ventilation for interventional pulmonary medicine: the ease of nasal superimposed high frequency jet ventilation. J Cancer. 2018;9(5):816–833.
  • Hong W, Yoon SH, Goo JM, et al. Cone-Beam CT-guided percutaneous transthoracic needle lung biopsy of juxtaphrenic lesions: diagnostic accuracy and complications. Korean J Radiol. 2021;22(7):1203.
  • Verhoeven RLJ, van der Sterren W, Kong W, et al. and augmented fluoroscopy-guided navigation bronchoscopy: radiation exposure and diagnostic accuracy learning curves. J Bronchology Interv Pulmonol. 2021;Publish Ahead of Print. https://doi.org/10.1097/LBR.0000000000000783
  • Zheng X, Xie F, Li Y, et al. Ultrathin bronchoscope combined with virtual bronchoscopic navigation and endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions with or without fluoroscopy: a randomized trial. Thorac Cancer. 2021;12(12):1864–1872.
  • Muthu V, Sehgal IS, Dhooria S, et al. Endobronchial ultrasound-guided transbronchial needle aspiration: techniques and challenges. J Cytol. 2019;36(1):65–70.
  • Di Felice C, Young B, Matta M. Comparison of specimen adequacy and diagnostic accuracy of a 25-gauge and 22-gauge needle in endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Dis. 2019;11(8):3643–3649.
  • Zarogoulidis P, Huang H, Zhou J, et al. Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons. Expert Rev Med Devices. 2021;18(2):197–201.
  • Plones T, Mardanzai K, Gafencu D, et al. Cytology versus histology in the primary diagnosis of lymphoma located in the mediastinum. Ann Thorac Surg. 2019;108(1):244–248.
  • Sapalidis K, Romanidis K, Oikonomou P, et al. Convex endobronchial ultrasound: same coin, two faces. Challenging biopsy and staging for non-small-cell lung cancer. 2020;8(4):LMT20.Lung cancer management
  • Clementsen PF, Bodtger U, Konge L, et al. Diagnosis and staging of lung cancer with the use of one single echoendoscope in both the trachea and the esophagus: a practical guide. Endosc Ultrasound. 2021.
  • Zarogoulidis P, Sapalidis K, Fyntanidou V, et al. Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy. Expert Rev Respir Med. 2019;13(12):1153–1159.
  • Zarogoulidis P, Kosmidis C, Fyntanidou V, et al. Elastography during convex-probe (endobronchial ultrasound) for optimal biopsy sample and gene identification in non-small-cell lung cancer. Biomark Med. 2019;13(14):1153–1156.
  • Huang H, Huang Z, Wang Q, et al. Effectiveness of the benign and malignant diagnosis of mediastinal and hilar lymph nodes by endobronchial ultrasound elastography. J Cancer. 2017;8(10):1843–1848.
  • Hu H, Li C, Lv T, et al. Contrast-enhanced computed tomography prior to percutaneous transthoracic needle biopsy reduces the incidence of hemorrhage. Ann Transl Med. 2021;9(4):288.
  • Cardoso AV, Neves I, Magalhaes A, et al. The value of rapid on-site evaluation during EBUS-TBNA. Revista portuguesa de pneumologia. 2015;21(5):253–258.
  • Mallya V, Kumar SP, Meganathan P, et al. The utility of ROSE (rapid on-site evaluation) in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA): is the picture rosy? J Cytol. 2015;32(4):230–233.
  • Papachristos A, Sivolapenko GB, Pharmacogenomics P. Pharmacogenomics, pharmacokinetics and circulating proteins as biomarkers for bevacizumab treatment optimization in patients with cancer: a review. J Pers Med. 2020;10(3):79.
  • Jiang W, Cai G, Hu PC, et al. Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective. Acta Pharmaceutica Sinica B. 2018;8(4):530–538.
  • Ang HX, Chan SL, Sani LL, et al. Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries. Pharmacogenomics. 2017;18(9):891–910.
  • Bhullar KS, Lagaron NO, McGowan EM, et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17(1):48.
  • Shackelford RE, Ansari JM, Wei EX, et al. Anaplastic lymphoma kinase rearrangements in non-small-cell lung cancer: novel applications in diagnostics and treatment. Pharmacogenomics. 2017;18(12):1179–1192.
  • Wang L, Wang H, Song D, et al. New strategies for targeting drug combinations to overcome mutation-driven drug resistance. Semin Cancer Biol. 2017;42:44–51.
  • Kosmidis C, Koimtzis G, Giannakidis D, et al. Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients. Int Med Case Rep J. 2019;12(15):15–20.
  • Lai L, Meng W, Wei J, et al. Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports. Medicine (Baltimore). 2021;100(10):e25046.
  • Wang W, Xu C, Chen H, et al. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: a multicenter retrospective study. Lung Cancer. 2021;155(20):20–27.
  • Niitsu T, Shiroyama T, Miyake K, et al. Combined small cell lung carcinoma harboring ALK rearrangement: a case report and literature review. Thorac Cancer. 2020;11(12):3625–3630.
  • Zhang T, Xu Z, Liu G, et al. Simultaneous Identification of EGFR,KRAS,ERBB2, and TP53 mutations in patients with non-small cell lung cancer by machine learning-derived three-dimensional radiomics. Cancers (Basel). 2021;13(8):8.
  • Novaes LAC, Sussuchi da Silva L, De MP, et al. Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients. Transl Lung Cancer Res. 2021;10(1):292–303.
  • Pickering EM, Holden VK, Heath JE, et al. Tissue acquisition during EBUS-TBNA: comparison of cell blocks obtained from a 19G Versus 21G Needle. J Bronchology Interv Pulmonol. 2019;26(4):237–244.
  • Santos RSD, Jacomelli M, Franceschini JP, et al. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in diagnosis of mediastinal lesions. Einstein. 2018;16(2):eAO4094.
  • Kinoshita T, Ujiie H, Schwock J, et al. Clinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle. J Thorac Dis. 2018;10(4):2388–2396.
  • Pisapia P, Pepe F, Iaccarino A, et al. Next generation sequencing in cytopathology: focus on non-small cell lung cancer. Front Med (Lausanne). 2021;8(633923). https://doi.org/10.3389/fmed.2021.633923.
  • An YS, Yoon JK, Lee MH, et al. False negative F-18 FDG PET/CT in non small cell lung cancer bone metastases. Clin Nucl Med. 2005;30(3):203–204.
  • Bustos Garcia de Castro A, Ferreiros DJ, Delgado BR, et al. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings. Radiologia. 2017;59(2):147–158.
  • Matilla JM, Zabaleta M, Martinez-Tellez E, et al. TNM staging in lung cancer (8(th) edition) and future perspectives. Journal of clinical and translational research. 2020;6(4):145–154.
  • Visser MPJ, van Grimbergen I, Holters J, et al. Performance insights of endobronchial ultrasonography (EBUS) and mediastinoscopy for mediastinal lymph node staging in lung cancer. Lung Cancer. 2021;156:122–128.
  • Goyal D, Shriwastav R, Mittal R, et al. Role of 18F-FDG PET/CT in the assessment of response to antitubercular chemotherapy and identification of treatment endpoint in patients with tuberculosis of the joints: a pilot study. Clin Nucl Med. 2021;46(6):449–455.
  • Why CP. When to request for a pet/Ct scan in a lung cancer patient? Revista portuguesa de cirurgia cardio-toracica e vascular: orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular. 2020;27(3):167–177.
  • Ravikanth R. 18F-fluorodeoxyglucose positron emission tomography/ computed tomography imaging review of benign lesions of the thorax. World J Nucl Med. 2021;20(1):7–16.
  • Yoo JY, Yoo MY, Lee KH, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in descending necrotizing mediastinitis and cervical vertebral osteomyelitis in a cancer patient: a case report. Medicine (Baltimore). 2020;99(30):e21353.
  • Wang Z, Li X, Zhang L, et al. Sputum cell-free DNA: valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs. Cancer Med. 2021 May;10(10):3323–3331. DOI: https://doi.org/10.1002/cam4.3817. Epub 2021 May 1.
  • Next-Generation HP. Sequencing with liquid biopsies from treatment-naive non-small cell lung carcinoma patients. Cancers (Basel). 2021;13(9):2049. DOI: https://doi.org/10.3390/cancers13092049.
  • Future R-PR. Perspectives on the TNM staging for lung cancer. Cancers (Basel). 2021;13(8):1940. DOI: https://doi.org/10.3390/cancers13081940.
  • Yuksel H, Yasar A, Acikel A, et al. Two different methods of lidocaine inhalation before diagnostic flexible bronchoscopy: effects on post-bronchoscopy respiratory symptoms. Turk J Med Sci. 2021.
  • Paul M, Rastogi A, Chatterje A, et al. Comparative evaluation of propofol and combination of propofol-dexmedetomidine in adjunct with topical airway anesthesia for rigid bronchoscopy: a randomized double-blinded prospective study. Ann Card Anaesth. 2021;24(1):49–55.
  • Gupta Y, Kriplani TC, Priya V. Comparative evaluation of sevoflurane, propofol, and combination of sevoflurane and propofol on insertion characteristics of reusable classic laryngeal mask airway. Anesthesia: Essays and Researches. 2018;12(2):386–391.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.